[Fingolimod (multiple sclerosis in children and adolescents) - Addendum to Commission A18-87]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003550
German
Original Title:
Fingolimod (multiple Sklerose bei Kindern und Jugendlichen) - Addendum zum Auftrag A18-87
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a19-42.html
Year Published:
2019
URL for published report:
https://www.iqwig.de/download/A19-42_Fingolimod_Addendum-zum-Auftrag-A18-87_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Multiple Sclerosis, Relapsing-Remitting
- Child
- Adolescent
- Fingolimod Hydrochloride
- Immunosuppressive Agents
Keywords
- Fingolimod
- Multiple Sclerosis ? Relapsing-Remitting
- Benefit Assessment
- NCT01892722
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.